-
-
-
-
-
-
-
NeoGenomics (NEO) Reports In-Line Q1 EPS ; Offers Guidance
-
-
-
-
-
-
-
Neogenomics (NEO) PT Raised to $15 at Needham
-
-
-
-
-
-
-
NeoGenomics (NEO) Tops Q3 EPS by 1c
-
-
-
-
-
-
-
NeoGenomics launches blood-based cancer test PanTracer LBx
-
-
-
-
-
-
-
NeoGenomics (NEO) Debuts PanTracer Family of Genomic Profiling Tests
-
-
-
-
-
-
-
Benchmark Reiterates Hold Rating on Neogenomics (NEO)
-
-
-
-
-
-
-
Neogenomics (NEO) PT Lowered to $17 at BTIG
-
435,061 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

